These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22489004)

  • 1. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells.
    Nettersheim D; Westernströer B; Haas N; Leinhaas A; Brüstle O; Schlatt S; Schorle H
    Genes Chromosomes Cancer; 2012 Jul; 51(7):717-26. PubMed ID: 22489004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
    Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
    Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
    Nonaka D
    Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCam-2 but not JKT-1 cells resemble seminoma in cell culture.
    Eckert D; Nettersheim D; Heukamp LC; Kitazawa S; Biermann K; Schorle H
    Cell Tissue Res; 2008 Feb; 331(2):529-38. PubMed ID: 18008088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors.
    Lau SK; Weiss LM; Chu PG
    Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
    Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of SOX2 inhibition for embryonal carcinoma.
    Ushida H; Chano T; Minami K; Kita H; Kawakami T; Okabe H; Okada Y; Okamoto K
    J Urol; 2012 May; 187(5):1876-81. PubMed ID: 22425046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
    Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
    Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma.
    Nettersheim D; Gillis AJ; Looijenga LH; Schorle H
    Int J Androl; 2011 Aug; 34(4 Pt 2):e189-203. PubMed ID: 21649665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma.
    Bouskine A; Vega A; Nebout M; Benahmed M; Fénichel P
    Int J Androl; 2010 Feb; 33(1):54-63. PubMed ID: 19226408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between intratubular seminoma and invasive germ cell tumors.
    Berney DM; Lee A; Shamash J; Oliver RT
    Hum Pathol; 2006 Apr; 37(4):458-61. PubMed ID: 16564921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of the first seminoma cell line TCam-2.
    de Jong J; Stoop H; Gillis AJ; Hersmus R; van Gurp RJ; van de Geijn GJ; van Drunen E; Beverloo HB; Schneider DT; Sherlock JK; Baeten J; Kitazawa S; van Zoelen EJ; van Roozendaal K; Oosterhuis JW; Looijenga LH
    Genes Chromosomes Cancer; 2008 Mar; 47(3):185-96. PubMed ID: 18050305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
    Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
    Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
    Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
    Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells.
    Ferranti F; Muciaccia B; Ricci G; Dovere L; Canipari R; Magliocca F; Stefanini M; Catizone A; Vicini E
    Int J Androl; 2012 Oct; 35(5):758-68. PubMed ID: 22519471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
    Cheng CJ; Wu YC; Shu JA; Ling TY; Kuo HC; Wu JY; Chang EE; Chang SC; Huang YH
    J Biomed Sci; 2007 Nov; 14(6):797-807. PubMed ID: 17682839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.